TCMP
AMGN icon

Thrive Capital Management (Pennsylvania)’s Amgen AMGN Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Sell
4,477
-13
-0.3% -$4.45K 0.31% 93
2026
Q1 		$1.58M Sell
4,490
-136
-3% -$48.5K 0.35% 91
2025
Q4 		$1.51M Sell
4,626
-814
-15% -$258K 0.34% 91
2025
Q3 		$1.54M Sell
5,440
-1,367
-20% -$396K 0.4% 87
2025
Q2 		$1.9M Buy
6,807
+6,016
+761% +$1.7M 0.6% 73
2025
Q1 		$247K Buy
+791
New +$234K 0.15% 105
2024
Q4 		– Sell
-878
Closed -$283K – 100
2024
Q3 		$283K Sell
878
-235
-21% -$76.9K 0.13% 157
2024
Q2 		$348K Sell
1,113
-3,421
-75% -$1.01M 0.16% 149
2024
Q1 		$1.29M Buy
4,534
+3,333
+278% +$975K 0.69% 24
2023
Q4 		$346K Sell
1,201
-808
-40% -$220K 0.19% 88
2023
Q3 		$540K Buy
2,009
+91
+5% +$22.7K 0.3% 54
2023
Q2 		$426K Buy
1,918
+686
+56% +$159K 0.24% 70
2023
Q1 		$298K Buy
1,232
+388
+46% +$95.2K 0.19% 90
2022
Q4 		$222K Sell
844
-835
-50% -$224K 0.15% 108
2022
Q3 		$378K Buy
+1,679
New +$407K 0.26% 70

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s AMGN Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Amgen (AMGN) stake by 0.29% in Q2 2026, selling an estimated $4.45K and leaving 4,477 shares worth $1.62M. The position accounts for 0.31% of the portfolio, ranked #93.

Thrive Capital Management (Pennsylvania) first reported a position in AMGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.9M in Q2 2025. 3,154 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 4,477 shares of Amgen worth $1.62M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) sold 13 Amgen shares in Q2 2026, an estimated $4.45K.
  • Amgen made up 0.31% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #93 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Amgen in Q3 2022 and has held it in 15 quarters since.
  • Thrive Capital Management (Pennsylvania)'s Amgen position peaked at $1.9M in Q2 2025.
  • 3,154 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.